Zusammenfassung
Klinisch relevante, isolierte Metastasen eines malignen Tumors in der Schilddrüse stellen eine absolute Rarität dar. Der Primarius findet sich meist in der Niere in Form eines hellzelligen Nierenzellkarzinoms. Eine Besonderheit dieser klinischen Situation ist ein relativ spätes metachrones Auftreten: eine isolierte Schilddrüsenmetastasierung tritt durchschnittlich 100-120 Monate nach Entfernung des Primärtumors auf. Die operative Sanierung sollte angestrebt werden, da nach Resektion solitärer Schilddrüsenmetastasen eines Nierenzellkarzinoms eine 5-Jahres-Überlebensrate von bis zu 50 % erreicht werden kann. Wir berichten über drei Patienten mit operativ entfernten Schilddrüsenmetastasen eines Nierenzellkarzinoms und liefern eine Literaturübersicht zu diesem Thema.
Abstract
Clinically significant, solitary metastasis to the thyroid gland is a rare occurrence. The clear cell carcinoma of the kidney (RCC) is the most common primary tumor site. Late recurrence is a notable feature of renal carcinoma. Solitary metastases in the thyroid gland occur as late as 100-120 months from the date of nephrectomy. There is a clear survival benefit in selected cases if surgical approach to the thyroid metastases is chosen. In those patients who have undergone complete resection, 5-year-survival-rates of 50 % have been reported. We describe 3 cases of surgically treated thyroid metastases of RCC, and review the literature.
Schlüsselwörter
Nierenzellkarzinom - Metastasen - Schilddrüse
Key words
renal cell carcinoma - metastases - thyroid gland
Literatur
1
Chen H, Nicol T L, Udelsman R.
Clinically significant, isolated metastatic disease to the thyroid gland.
World J Surg.
1999;
23
177-180
2
Congiu A, Nicolosi A, Malloci A, Piga A, Calo P G, Murtas M G.
Metastasi tiroidea e cutanea isolate de carcinoma renale.
Minerva Chir.
1994;
49
223-227
3
Curti B D.
Renal cell carcinoma.
JAMA.
2004;
292
97-100
4
DiBiase S J, Valicenti R K, Schultz D, Xie Y, Gomella L G, Corn B W.
Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model.
J Urol.
1997;
158
746-749
5
Ericsson M, Biorklund A, Cederquist E, Ingemansson S, Akerman M.
Surgical treatment of metastatic disease in the thyroid gland.
J Surg Oncol.
1981;
17
15-23
6
Gault E W, Leung T H, Thomas D P.
Clear cell renal carcinoma masquerading as thyroid enlargement.
J Pathol.
1974;
113
21-25
7
Heffess C S, Wenig B M, Thompson L D.
Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases.
Cancer.
2002;
95
1869-1878
8
Hudson M A, Kavoussi L R, Catalona W J.
Bilateral renal cell carcinoma with metastasis to thyroid.
Urology.
1991;
37
145-148
9
Jadvar H, Kherbache H M, Pinski J K, Conti P S.
Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma.
Clin Nephrol.
2003;
60
395-400
10
Kang D E, White Jr R L, Zuger J H, Sasser H C, Teigland C M.
Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.
J Urol.
2004;
171
1806-1809
11
Kavolius J P, Mastorakos D P, Pavlovich C, Russo P, Burt M E, Brady M S.
Resection of metastatic renal cell carcinoma.
J Clin Oncol.
1998;
16
2261-2266
12
Kierney P C, van Heerden J A, Segura J W, Weaver A L.
Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review.
Ann Surg Oncol.
1994;
1
345-352
13
Leibovich B C, Blute M L, Cheville J C, Lohse C M, Frank I, Kwon E D, Weaver A L, Parker A S, Zincke H.
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
Cancer.
2003;
97
1663-1671
14
Majhail N S, Urbain J L, Albani J M, Kanvinde M H, Rice T W, Novick A C, Mekhail T M, Olencki T E, Elson P, Bukowski R M.
F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
J Clin Oncol.
2003;
21
3995-4000
15
Masuda H, Kawakami S, Nagamatsu H, Nagahama K, Yamada T, Negishi T.
[Two cases of thyroid metastases from renal cell carcinoma].
Hinyokika Kiyo.
1992;
38
821-824
16
McCabe D P, Farrar W B, Petkov T M, Finkelmeier W, O'Dwyer P, James A.
Clinical and pathologic correlations in disease metastatic to the thyroid gland.
Am J Surg.
1985;
150
519-523
17
Michelow P M, Leiman G.
Metastases to the thyroid gland: diagnosis by aspiration cytology.
Diagn-Cytopathol.
1995;
13
209-213
18
Motzer R J, Bacik J, Murphy B A, Russo P, Mazumdar M.
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.
J Clin Oncol.
2002;
20
289-296
19
Nakahara H, Noguchi S, Murakami N, Tamura S, Jinnouchi S, Kodama T, Adjei O N, Nagamachi S, Ohnishi T, Futami S, Flores 2nd
L G, Watanabe K.
Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
Radiology.
1997;
202
765-772
20
Nakhjavani M K, Gharib H, Goellner J R, van Heerden J A.
Metastasis to the thyroid gland. A report of 43 cases.
Cancer.
1997;
79
574-578
21
Pagano S, Franzoso F, Ruggeri P.
Renal cell carcinoma metastases. Review of unusual clinical metastases, metastatic modes and patterns and comparison between clinical and autopsy metastatic series.
Scand J Urol Nephrol.
1996;
30
165-172
22
Palazzo F F, Bradpiece H A, Morgan M W.
Renal cell carcinoma metastasizing to the thyroid gland.
Scand J Urol Nephrol.
1999;
33
202-204
23
Piltz S, Meimarakis G, Wichmann M W, Hatz R, Schildberg F W, Fürst H.
Long-term results after pulmonary resection of renal cell carcioma metastases.
Ann Thorac Surg.
2002;
73
1082-1087
24
Ritchie A W, Chisholm G D.
The natural history of renal carcinoma.
Semin Oncol.
1983;
10
390-400
25
Shimaoka K, Sokal J E, Pickren J W.
Metastatic neoplasms in the thyroid gland. Pathological and clinical findings.
Cancer.
1962;
15
557-565
26
Silverberg S G, Sokal J E, Pickren J W.
Metastatic tumors in the thyroid.
Pacif Med Surg.
1966;
74
175-180
27
Stenzl A, deKernion J B.
Pathology, biology, and clinical staging of renal cell carcinoma.
Semin Oncol.
1989;
16
3-11
28
Takashima S, Takayama F, Wang J C, Saito A, Kawakami S, Kobayashi S, Sone S.
Radiologic assessment of metastases to the thyroid gland.
J Comput Assist Tomogr.
2000;
24
539-545
29
van der Poel H G, Roukema J A, Horenblas S, van Geel A N, Debruyne F M.
Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis.
Eur Urol.
1999;
35
197-203
30
Wood K, Vini L, Harmer C.
Metastases to the thyroid gland: the Royal Marsden experience.
Eur J Surg Oncol.
2004;
30
583-588
Dr. I. Iesalnieks
Klinik und Poliklinik für Chirurgie · Universitätsklinikum Regensburg
Franz-Josef-Strauß-Allee 11
93053 Regensburg
Phone: 09 41/9 44 68 01
Fax: 09 41/9 44 68 02
Email: igors.iesalnieks@klinik.uni-regensburg.de